Mark E. Saad - 07 Jun 2024 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXSM	Stock Option (Right to Buy)	Award	$0	+5,799		$0.000000	5,799	07 Jun 2024	Common Stock	5,799	$73.90	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The options vest in full on the one-year anniversary of the date of grant, June 7, 2025.